𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease

✍ Scribed by U. HINDORF; M. JOHANSSON; A. ERIKSSON; E. KVIFORS; S. H. C. ALMER

Book ID
108605551
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
148 KB
Volume
29
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased dosing requirements for 6-merc
Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger
✍ Andrew B. Grossman; Angela J. Noble; Petar Mamula; Robert N. Baldassano πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

## Background: 6-mercaptopurine (6-mp) and its prodrug azathioprine (aza) are effective for the induction and maintenance of remission and reduction of corticosteroid exposure for pediatric inflammatory bowel disease (ibd). the standard dose of 6-mp is 1.0-1.5 mg/kg/day and for aza is 2.0-2.5 mg/kg

Incidence of nodular regenerative hyperp
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine
✍ Philippe Seksik; Jean-Yves Mary; Laurent Beaugerie; Marc LΓ©mann; Jean-Frederic C πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 224 KB πŸ‘ 1 views

Background: Nodular regenerative hyperplasia (NRH) is a rare hepatic disorder that may lead to severe portal hypertension. Cases of NRH have been reported in patients receiving thiopurines for inflammatory bowel disease (IBD). Since azathioprine (AZA) is used more and more frequently as a maintenanc